Fosfomycin in the treatment of extended spectrum beta-lactamaseproducing Enterobacteriaceae- related urinary tract infections

Abstract

Introduction: We aimed to demonstrate if fosfomycin tromethamine (FT) treatment could be the treatment of choice in ESBL-producing Enterobacteriaceae strains as an alternative to carbapenem particularly in patients who we would like to treat on an outpatient basis.